REPLAY: City of Amarillo COVID-19 Zoom meeting 6/17/2020

Local News

AMARILLO, Texas (KAMR/KCIT) — Amarillo hospitals are continuing to relax restrictions on visitation.

Northwest Texas Hospital said it is still limiting one visitor per room between the hours of 12 p.m. and 8 p.m., except for labor and delivery.

Northwest is also starting to allow two visitors to a room on the pediatrics floor.

At BSA, they are still limiting visitation to one per patient except in certain circumstances where it’s important to have two visitors. BSA said it is continuing to do extra cleaning and is screening those who enter the hospital.

A new treatment for COVID-19 patients is at local hospitals. It’s called “dexamethasone.”

The drug is best used in those who have developed respiratory distress. It’s a steroid drug and also an anti-inflammatory medicine.

Medical experts say this has been used in other infections, and the mortality rate has shown to be lower.

Health leaders said they are still using remdesivir to treat COVID-19 patients.

They have treated seven people with that drug so far, and they have enough to treat another 40 people if needed.

(This table reflects the cases on the High Plains as of 5:00 p.m. on November 26, 2020.)

CountyConfirmed Cases ReportedDeathsRecovery
Armstrong48131
Beaver1782142
Briscoe40124
Carson95268
Castro4628358
Childress830641
Cimarron7257
Collingsworth38124
Cottle56449
Curry3,01217984
Dallam7429605
Deaf Smith1,726381,615
Donley111193
Gray1,26510599
Hall80351
Hardeman84477
Hansford2289205
Hartley4766383
Hemphill2862235
Hutchinson63122464
Lipscomb121192
Moore1,612291,419
Ochiltree5336407
Oldham39230
Parmer69022603
Potter12,3601768,819
Quay217377
Randall10,4431086,158
Roberts2719
Roosevelt94313317
Sherman156586
Swisher2708182
Texas2,318122,094
Union107427
Wheeler2917238
TOTAL40,58754127,614
CLICK HERE FOR MORE CORONAVIRUS COVERAGE

More from MyHighPlains.com:

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Video Forecast

More Forecast

Don't Miss